Latest Breaking News On - Rocket pharma - Page 1 : comparemela.com

Regenxbio CEO to step down after 15 years

BioPharma

Anabel samimyCurran simpsonEli lillyNovarti zolgensmaDrug administrationKenneth millsRocket pharma

Rocket Pharma Seeks Gene Therapy Revolution For Genetic Heart Disease

Rocket Pharma has a pipeline of six gene therapy programs addressing cardiovascular and hematology-based diseases at the genetic level.

Kinnari patelGaurav shahJonathan schwartzRocket pharmaceuticalsChief gene therapy officerDanon diseaseBiologics evaluationPhase twoRocket pharmaGene therapy

Lexeo s IPO Raises $100M for Gene Therapies That Treat the Heart, Protect the Brain

The gene therapy programs of Lexeo Therapeutics span rare forms of cardiomyopathy and certain types of Alzheimer’s disease. But Lexeo’s IPO comes as a rival gene therapy developer sues the biotech, claiming its work employs stolen trade secrets.

New yorkUnited statesCornell universityNolan townsendRocket pharmaceuticalsRocket pharmaceuticals incLexeo therapeuticsNew york based lexeoLexeo alzheimerYork based lexeoRonald crystalWeill cornell medicineFaces litigation fromGene therapySouthern districtNew jersey based

Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Rocket Pharmaceuticals, Inc. , a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today.

Bruxelles capitaleEnfermedades rarasJonathan schwartzKinnari patelMedioambientalesy tecnolBitha narayananInvestigaciones energEuropean society of gene cell therapyRocket pharmaceuticals incRocket pharmaceuticalsAnnual congressEuropean societyCell therapyPyruvate kinase deficiencyFanconi anemiaDanon disease

Rocket Pharmaceuticals, Inc : Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Rocket Pharmaceuticals, Inc : Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Bruxelles capitaleIhre chancenIndiens wirtschaftKinnari patelJonathan schwartzEnfermedades rarasInvestigaciones energBitha narayananMedioambientalesy tecnolKevin giordanoEuropean society of gene cell therapyRocket pharmaceuticals incRocket pharmaceuticalsAnnual congressEuropean societyGene cell therapy